Sleep Therapy Articles & Analysis
11 news found
Have you heard of the sensory phenomenon known as ASMR for sleep? ASMR stands for autonomous sensory meridian response, a condition, experience, or phenomenon that helps you fall asleep. ...
Unlike other treatment options, this does not require a nighttime wearable, which allows patients to conveniently fit therapy into their daily routine. The therapy works by using NMES to build endurance of the genioglossus muscle so that the tongue doesn’t collapse into the airway during sleep. ...
The data demonstrated that real-world patients in the US prescribed eXciteOSA, the first daytime therapy indicated to treat primary snoring and mild obstructive sleep apnea (OSA), exhibited strong adherence to the treatment by using therapy on over 80% of days over the first six weeks of treatment. ...
Prior to his time at Quanta, Lipman was Chief Commercial Officer at NightBalance for four years before its acquisition by Philips, where he was responsible for leading the U.S. launch of the Lunoa sleep therapy device. He was also Vice President of marketing and sales at ApniCure, where he deployed and expanded a U.S. sales team to launch a new treatment for ...
Signifier Medical Technologies Ltd, an innovator in the sleep-disordered breathing market, announced today that it has hit the 50,000 therapy session milestone with its innovative eXciteOSA® sleep device. ...
“The new Inspire physician programmer platform provides multiple key benefits for physicians when managing their patients’ sleep apnea treatment with Inspire therapy.” The new platform provides four key enhancements over the existing product. First, the new design incorporates guided workflows, which direct clinicians step-by-step through the ...
Signifier Medical Technologies (“Signifier” or “the Company”), an innovator in the sleep disordered breathing market, is pleased to announce the successful award of the UK Non-invasive Ventilation, Sleep Therapy and Sleep Monitoring Tender, which will confirm Signifier as an approved supplier to the ...
“This designation recognizes the real promise of aerSleep II as a first-in-class therapy for people with sleep apnea who are unable to benefit from current therapies,” remarked Dr. ...
This trial evaluated the safety, tolerability and effectiveness of the Sommetrics aerSleep™ product in ethnic Japanese subjects with obstructive sleep apnea (OSA). This was a prospective, observational study conducted at the American Academy of Sleep Medicine accredited Sleep Lab in Kaneohe, Hawaii. ...
Yet, only a small fraction of individuals with OSA are currently receiving effective therapy. It is this extraordinary medical need that our aerSleep™ system ...
“Sommetrics has an opportunity to substantially disrupt the sleep industry with its patented technology and bring leading-edge therapy to those around the globe who suffer from breathing disorders such as sleep apnea. ...